
Company Information
Ask for more detail from the seller
Contact SupplierMounjaro KwikPen is approved to treat adults with type 2 diabetes and for weight management in adult patients with a BMI of 30kg/m² or more (obesity), as well as those with a BMI between 27-30kg/m² (overweight) who also have weight-related health problems such as prediabetes, high blood pressure, high cholesterol, or heart problems.The medicine is to be used together with a reduced-calorie diet and increased physical activity.